Finance
By: Shree1news, 12 JAN 2021
India will send a limited amount of Covid-19 vaccines to neighbouring countries for “emergency use authorisation” under the grant-in-aid programme whereas commercial supplies will solely happen after the vaccines get market authorisation. The grant-in-aid restricted use to friendly neighbours can be rolled out quickly after the Indian roll-out on January 16, people acquainted with the matter stated.
Prime Minister Narendra Modi has made it clear that the commercial supplies of Serum’s Covishield and Bharat Biotech’s Covaxin to foreign countries ought to be done under the aegis of the external affairs ministry in consultation with the pharmaceutical ministry, a senior government official mentioned. PM Modi is in contact with the health ministry over the vaccine administration and is making certain that all authorities departments are in sync with one another as well as the private sector.
“As of now, globally all vaccines are being sold only to national governments under emergency use authorisation, whether it’s Pfizer or Moderna. The market authorisation is expected in the second quarter of the year, by which time the Phase 3 trial of all of the named vaccine contenders are completed,” mentioned a senior official.
Whereas the Modi government will buy 1.1 crore vials of vaccine by January 14, the shipping of “symbolic” quantities of the restricted use vaccine can be done immediately after the Indian roll-out.
Bangladesh has tied up with Serum India for commercial supply of 30 million vials. Nepal is seeking to procure 12 million vials from India aside from different neighbours such as Bhutan, Myanmar and Sri Lanka who’ve requested New Delhi for the Indian vaccines.
Officials mentioned the decision on the quantity of vaccine to be made accessible under the emergency use authorisation can be taken by the external affairs ministry, which had last year also coordinated supplies of Hydroxychloroquine in the early phase of the coronavirus pandemic.
Source: A-N
